Yum Brands Insider Sold Shares Worth $4,919,433, According to a Recent SEC Filing-February 2024-www.financetom.com

Yum Brands Insider Sold Shares Worth $4,919,433, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Yum Brands Insider Sold Shares Worth $4,919,433, According to a Recent SEC Filing

Mar 6, 2024 2:03 PM

04:38 PM EST, 03/06/2024 (MT Newswires) -- Tracy L Skeans, COO and Chief People Officer, on March 06, 2024, sold 35,363 shares in Yum Brands ( YUM ) for $4,919,433. Following the Form 4 filing with the SEC, Skeans has control over a total of 12,537 shares of the company, with 3,183 shares held directly and 9,354 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1041061/000112760224008818/xslF345X03/form4.xml

Previous page： Cirrus Logic Insider Sold Shares Worth $1,343,788, According to a Recent SEC Filing Next page： Zevra Therapeutics Q2 Net Loss Widens, Revenue Slumps

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Cirrus Logic Insider Sold Shares Worth $1,343,788, According to a Recent SEC Filing

Aug 13, 2024

05:47 PM EDT, 08/13/2024 (MT Newswires) -- Justin E Dougherty, Senior Vice President, Global Operations, on August 09, 2024, sold 10,203 shares in Cirrus Logic ( CRUS ) for $1,343,788. Following the Form 4 filing with the SEC, Dougherty has control over a total of 4,838 shares of the company, with 4,838 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/772406/000127390224000070/xslF345X03/wk-form4_1723585415.xml Price: 137.86,...

Zevra Therapeutics Q2 Net Loss Widens, Revenue Slumps

Aug 13, 2024

05:48 PM EDT, 08/13/2024 (MT Newswires) -- Zevra Therapeutics ( ZVRA ) posted a Q2 net loss late Tuesday of $0.48 per diluted share, compared with a loss of $0.08 a year ago. Analysts polled by Capital IQ expected a loss of $0.44. Revenue for the quarter that ended June 30 was $4.45 million, down from $8.47 million a year...

LL Flooring Shares to Be Delisted From NYSE Following Chapter 11 Bankruptcy Filing; Trading Suspended

Aug 13, 2024

05:46 PM EDT, 08/13/2024 (MT Newswires) -- LL Flooring Holdings ( LL ) said late Tuesday the New York Stock Exchange decided to commence the delisting process of the company's common stock and suspend trading immediately. The exchange determined that LL Flooring ( LL ) is no longer suitable for listing after the company and certain of its subsidiaries filed...

Acelyrin Skin Disease Candidate Meets Endpoint, Q2 Loss Widens, Restructuring Plan Involves Job Cuts

Aug 13, 2024

05:45 PM EDT, 08/13/2024 (MT Newswires) -- Acelyrin ( SLRN ) was up over 5% in extended session Tuesday, after saying its izokibep drug candidate met the primary endpoint of phase 3 testing in hidradenitis suppurativa, a skin disorder. Izokibep demonstrated its efficacy across multiple endpoints, including 33% of the patients with the long-term skin condition who were treated with...